Northern Biologics Email Format

Biotechnology ResearchOntario, Canada11-50 Employees

Northern Biologics is a biotechnology research company focused on developing therapeutic antibodies that target cancer and fibrosis by modulating key signaling pathways. Its work centers on antibody generation and disease biology, leveraging a phage display platform developed at the University of Toronto to create candidates with potential to influence the tumor microenvironment. The company aims to provide novel functional modulators that address oncology and fibrotic diseases, aligning with researchers and clinicians seeking targeted biologics.

Based in Toronto, Ontario, Northern Biologics operates within the biotechnology research sector and has positioned itself around advanced antibody technologies and mechanisms of action designed to affect disease pathways. The organization has a history tied to collaborations and activity in the broader biotech landscape, including notable industry movements in 2020, and maintains a focus on preclinical development and translational potential for its antibody candidates.

Sign up for free to view info

Company overview Employee directory